Navigation Links
New Migraine Drug Shows Promise
Date:8/14/2009

Orally inhaled therapy effective with few side effects, study finds

FRIDAY, Aug. 14 (HealthDay News) -- An experimental inhaled drug called Levadex is an effective treatment for migraines, according to a drug company-funded study.

The phase III trial, conducted at the Jefferson Headache Center at Thomas Jefferson University Hospital in Philadelphia, found that migraine patients who took the drug had greater relief from symptoms such as pain, nausea and light/sound sensitivity than those who took a placebo.

The drug provided pain relief within 30 minutes and sustained relief for 48 hours in patients with moderate or severe migraines. There were no drug-related, serious adverse effects, according to a news release issued by the university.

"The major advantage of Levadex is that it has the efficacy of intravenous DHE (dihydroergotamine) with a side-effect profile similar to placebo and better than oral triptans," Dr. Stephen Silberstein, director of the Jefferson Headache Center, and professor in the neurology department at Jefferson Medical College, said in the news release.

The study was funded by MAP Pharmaceuticals, Inc. Silberstein serves on the advisory board of the company.

More information

The American Academy of Family Physicians has more about migraine.



-- Robert Preidt



SOURCE: Thomas Jefferson University, news release, Aug. 11, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Neuromuscular Dentistry Ends Womans Migraines
2. Migraine Tied to Thickening in Brain Area
3. Business Coalition Honors BlueChoice HealthPlan for Migraine Program
4. The HealthCentral Network Wins eHealthcare Awards for Breast Cancer and Migraine Web Sites
5. MAP Pharmaceuticals Reaches Agreement with FDA on Special Protocol Assessment for MAP0004 Phase 3 Clinical Trial in Patients With Migraine
6. Comatose locusts may help relieve migraines
7. Epilepsy Drug Doesnt Prevent Migraines
8. MyMigraineConnection.com and Migraine Expert Teri Robert Announce Seventh Annual Migraine and Headache Poetry Contest
9. Migraines Frequency Influences Heart Attack, Stroke Risk
10. Overuse of Opioids, Barbiturates Boosts Chronic Migraine Risk
11. Skin Pain, Sensitivity Rises With Migraine
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Migraine Drug  Shows Promise
(Date:5/23/2013)... 23, 2013 Da Vinci surgical robot ... trial in Washington State May 23, according to Bloomberg.* ... surgical robot lawsuits , expresses disappointment in the ... lawsuits to not read a single verdict as representative ... of Fred E. Taylor v. Intuitive Surgical Inc.; 09-2-03136-5, ...
(Date:5/23/2013)... THURSDAY, May 23 (HealthDay News) -- Glucosamine supplements that ... knee osteoarthritis may have an unexpected side effect: They ... study of older adults suggests. Glaucoma occurs ... or pressure inside the eye. Left untreated, glaucoma is ... In the new study of 17 people, whose ...
(Date:5/23/2013)... People who eat at fast-food restaurants are consuming significantly ... the worst offenders, a new study found. "Teens ... as much as 34 percent, parents of school-age children ... as much as 20 percent," study lead researcher, Dr. ... Robert Wood Johnson Foundation, which helped fund the study. ...
(Date:5/23/2013)... Ohio (May 23, 2013)Don,t doubt it when a woman ... time remembering things. A new study published online in ... Menopause Society (NAMS), helps confirm with objective tests that ... , In the past, some studies showed that hot ... Other studies showed that, even though there was a ...
(Date:5/23/2013)... “Talk. They Hear You.” a new ... to talk to children as young as nine years ... today by the Substance Abuse and Mental Health Services ... with SAMHSA’s 2013 National Prevention Week—an annual health observance ... abuse and mental health issues. , SAMHSA’s latest report ...
Breaking Medicine News(10 mins):Health News:Da Vinci Surgical Robot Lawsuit News: Rottenstein Law Group LLP Comments on Intuitive Win in Negligent Training Trial 2Health News:Glucosamine Supplements Tied to Risk of Eye Condition 2Health News:Glucosamine Supplements Tied to Risk of Eye Condition 3Health News:How Many Calories in Your Fast-Food Meal? Guess Again 2Health News:New Campaign to Help Parents Talk to Younger Children About the Dangers of Underage Drinking 2
... 12 (HealthDay News) -- The U.S. Department of Health and ... $185 million to 13 states and the District of Columbia ... cornerstone of President Obama,s health care reform -- across the ... the plan, which will include tax relief to give families ...
... (HealthDay News) -- Dogs can teach children about responsibility, ... maintain their reading skills. Researchers found that reading ... some second-graders, ability to read and their attitude about ... adults experienced declines in both areas, the study found. ...
... -- Although being physically active is one of the best ... ability to get around, a new study shows that people ... thought. Researchers from Northwestern University Feinberg School of Medicine ... of men with knee osteoarthritis are basically "couch potatoes," and ...
... Aug. 12 (HealthDay News) -- Monthly premiums for individual health ... vary widely from state to state, a new report says. ... $136 a month in Alabama to more than $400 a ... the non-profit Kaiser Family Foundation. The foundation said the ...
... published in the American Journal of Industrial Medicine ... of the New York City Fire Department (FDNY) resulting ... David J. Prezant, MD, Chief Medical Officer, FDNY, researchers ... 11, 1994, and September 10, 2008, comparing the total ...
... Hawn Foundation, will present a lecture for the public ... jointly sponsored by the New York Academy of Sciences ... about the MindUP curriculum, the Foundation,s signature educational initiative ... emotional learning program designed for pre-kindergarten through eighth-grade children, ...
Cached Medicine News:Health News:Feds Outline Rules for States' Insurance Exchanges 2Health News:Fido's New Forte: Helping Kids Learn to Read 2Health News:Many Arthritis Patients May Not Be Exercising Enough 2
(Date:5/23/2013)... -- Haemonetics Corporation (NYSE: HAE ) announced today that ... will present at The Deutsche Bank 38 th Annual ... on May 29, 2013 at 1:30pm Eastern time.  ... public may access Mr. Lindop,s presentation live via webcast at: ... Haemonetics (NYSE: HAE ) is a global healthcare ...
(Date:5/23/2013)... May 23, 2013  TeamHealth Medical Call Center ... and nurse advice lines, announces its newly formed ... nursing and administrative leaders, provides clinical expertise to ... cost-effective services for hospital clients, physician clients and ... system evolves, it,s imperative to continuously advance our ...
(Date:5/23/2013)... ARBOR, Mich. , May 23, 2013  Every day, ... flow of air to his lungs. April and ... the dire predictions weren,t true. "Quite a few ... the hospital alive," says April Gionfriddo , ... were desperate. Anything that would work, we would take it ...
Breaking Medicine Technology:TeamHealth Medical Call Center Forms Clinical Advisory Committee 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4
... Mass. and TOKYO, Nov. 10 Ironwood Pharmaceuticals, ... they have entered into an agreement providing Astellas ... compound linaclotide in Japan, Indonesia, Korea, the Philippines, ... 3 clinical development in the United States for ...
... Inc. today announced that it has enrolled the 100th patient ... stenosis. "We are well ahead of our projections for 2009," ... the market need, the clinical outcomes that surgeons are seeing, ... Over 1.5 million people are diagnosed with lumbar spinal stenosis ...
Cached Medicine Technology:Ironwood and Astellas Announce Japan Licensing Agreement for Linaclotide 2Ironwood and Astellas Announce Japan Licensing Agreement for Linaclotide 3Facet Solutions Enrolls 100th Patient in US Pivotal IDE Study 2